- Capital Cube•last month
Click here to see latest analysisCapitalcube gives Cambrex Corp. a score of 88.Our analysis is based on comparing Cambrex Corp. with the following peers – Aceto Corporation, Codexis, Inc., Bioanalytical Systems, Inc., Albany Molecular Research, Inc., Teligent, Inc., Meridian Bioscience, Inc., Elite Pharmaceuticals, Inc., International Isotopes Inc., Natural Alternatives International, Inc. and Cyanotech Corporation (ACET-US, […] (Read more...) The post Cambrex Corp. – Value Analysis (NYSE:CBM) : June 21, 2016 appeared first on CapitalCube.
After hours: 49.750.02 (0.04%) as of 6:00 PM EDT
|Bid||49.75 x 200|
|Ask||65.00 x 1000|
|52wk Range||29.50 - 59.41|
|Day's Range||49.69 - 55.95|
|Avg Vol (3m)||367,253|
As of 4:02 PM EDT. Market closed.